Text Size

Determination of Glycemic Index (GI) of Ten Food Products

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Danone Asia Pacific Holdings Pte, Ltd.
ClinicalTrials.gov Identifier:
NCT01679704
First received: August 30, 2012
Last updated: September 5, 2012
Last verified: September 2012
History of Changes
  Purpose

This study is initiated to investigate the glycemic index value of ten food products.


Condition Intervention
Glycemic Index
 Dietary Supplement: Food products

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Determination of Glycemic Index (GI) of Ten Food Products

Further study details as provided by Danone Asia Pacific Holdings Pte, Ltd.:

Primary Outcome Measures:
  • Glycemic index values of all ten products [ Time Frame: 120 minutes post adminstration ] [ Designated as safety issue: No ]
    Glycemic index values at 120 minutes post adminstration.


Enrollment: 15
Study Start Date: August 2012
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Food products
Ten food products will be given to all subjects
 Dietary Supplement: Food products

  Eligibility

Ages Eligible for Study:   21 Years to 60 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy non-pregnant females (at least 6 weeks postpartum, non-lactating)
  • Age between 21 to 60 years

Exclusion Criteria:

  • Suffering from any chronic diseases.
  • Suffering from gastrointestinal diseases that may interfere with nutrient absorption, distribution, metabolism and excretion.
  • History of diabtes mellitus or use of antihyperglycemic drugs or insulin to treat diabetes and related conditions.
  • History of AIDS, hepatitis, renal or heart disease or any other serious complications that may interfere with glucose metabolism.
  • Current use of medication that may interfere with the digestion and nutrient absorption (for examples steriods, protease inhibitors or antipsychotics medications).
  • Current use of medication known to affect glucose tolerance (excluding oral contraceptives).
  • Known food allergy or intolerance.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01679704

Locations
Singapore
Temasek Polytechnic
Singapore, Singapore
Sponsors and Collaborators
Danone Asia Pacific Holdings Pte, Ltd.
Investigators
Principal Investigator: Kalpana Bhaskaran, Dr Temasek Polytechnic
  More Information

No publications provided

Responsible Party: Danone Asia Pacific Holdings Pte, Ltd.
ClinicalTrials.gov Identifier: NCT01679704     History of Changes
Other Study ID Numbers: GIS.2012
Study First Received: August 30, 2012
Last Updated: September 5, 2012
Health Authority: Singapore: Ministry of Health

ClinicalTrials.gov processed this record on May 23, 2013